Interferon alpha-2A (roferon) as a treatment of inflammatory bowel disease in children and adolescents
- PMID: 7502809
Interferon alpha-2A (roferon) as a treatment of inflammatory bowel disease in children and adolescents
Similar articles
-
The incidence of colonic natural killer cells, large granular lymphocytes and mast cells in inflammatory bowel disease.Adv Exp Med Biol. 1995;371B:1261-6. Adv Exp Med Biol. 1995. PMID: 7502796 No abstract available.
-
Distribution and density of TNF immunoreactivity in chronic inflammatory bowel disease.Adv Exp Med Biol. 1995;371B:1327-30. Adv Exp Med Biol. 1995. PMID: 7502810 No abstract available.
-
Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).Hepatogastroenterology. 1998 May-Jun;45(21):691-9. Hepatogastroenterology. 1998. PMID: 9684118
-
Pathology of inflammatory bowel disease.Semin Pediatr Surg. 2007 Aug;16(3):154-63. doi: 10.1053/j.sempedsurg.2007.04.005. Semin Pediatr Surg. 2007. PMID: 17602970 Review.
-
Immunopathogenesis of inflammatory bowel disease: role of cytokines and immune cell-enterocyte interactions.Nestle Nutr Workshop Ser Clin Perform Programme. 1999;2:41-57; discussion 58-61. doi: 10.1159/000061779. Nestle Nutr Workshop Ser Clin Perform Programme. 1999. PMID: 11490627 Review. No abstract available.
Cited by
-
Type I interferons for induction of remission in ulcerative colitis.Cochrane Database Syst Rev. 2015 Sep 14;2015(9):CD006790. doi: 10.1002/14651858.CD006790.pub3. Cochrane Database Syst Rev. 2015. PMID: 26368001 Free PMC article.
-
Medical approaches and future options in chronic active ulcerative colitis.Int J Colorectal Dis. 2004 Jul;19(4):297-307. doi: 10.1007/s00384-003-0569-x. Epub 2004 Jan 15. Int J Colorectal Dis. 2004. PMID: 14727131 Review.